New York, NY -- (SBWIRE) -- 01/24/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Arcos Dorados Holding Inc (NYSE:ARCO), National Bank of Greece (ADR) (NYSE:NBG), New Gold Inc. (USA) (NYSEMKT:NGD), Atossa Genetics Inc (NASDAQ:ATOS)
Arcos Dorados Holding Inc (NYSE:ARCO) showed a volume of 2.88 million shares by the end of last trade whereas the average volume of the stock remained 865,879 shares. The stock opened the session at $10.03 but then moved to $9.54. At that price, the stock showed a negative performance of -6.10%. Arcos Dorados Holdings Inc is an Argentina-based company engaged in the operation of McDonald’s franchisees. The Company serves over 4 million customers through the operation of 1,840 McDonald’s-branded restaurants in 20 Latin American countries.
Will ARCO Get Buyers Even After The Recent Rally? Find Out Here
National Bank of Greece (ADR) (NYSE:NBG) opened the session at $5.40 and closed the session at $5.26. The stock showed a negative performance of -1.50% in previous trading session. Traded with volume of 2.84 million shares in the prior session and the average volume of the stock remained 3.07 million shares. National Bank of Greece SA (the Bank) is a Greece-based financial institution. It provides a range of financial services including retail and commercial banking, asset management, brokerage, investment banking, insurance and real estate at a global level.
Has NBG Found The Bottom And Ready To Gain Momentum? Find Out Here
New Gold Inc. (USA) (NYSEMKT:NGD) opened the session at $5.72 and closed the session at $5.83. The stock showed a positive performance of 3.55% in previous trading session. Traded with volume of 2.83 million shares in the prior session and the average volume of the stock remained 3.65 million shares. The beta of the stock remained 0.04. New Gold Inc. is engaged in gold mining and related activities, including acquisition, exploration, extraction, processing and reclamation. Its operating assets consist of the Mesquite gold mine (Mesquite Mine) in the United States.
Why Should Investors Buy NGD After The Recent Gain? Just Go Here and Find Out
Atossa Genetics Inc (NASDAQ:ATOS) the stock advanced 5.96% and finished the session at $3.20. Traded with volume of 3.11 million shares in the prior session and the average volume of the stock remained 398,490.00 shares. Atossa Genetics Inc. is a development-stage healthcare company focused on the prevention of breast cancer through the commercialization of diagnostic tests that can detect precursors to breast cancer, and through the research, development.
Will ATOS Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)